These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 22314936)

  • 1. A pragmatic randomised controlled trial of the effectiveness and cost-effectiveness of screening older women for the prevention of fractures: rationale, design and methods for the SCOOP study.
    Shepstone L; Fordham R; Lenaghan E; Harvey I; Cooper C; Gittoes N; Heawood A; Peters T; O'Neill T; Torgerson D; Holland R; Howe A; Marshall T; Kanis J; McCloskey E
    Osteoporos Int; 2012 Oct; 23(10):2507-15. PubMed ID: 22314936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Cost-Effectiveness of Screening in the Community to Reduce Osteoporotic Fractures in Older Women in the UK: Economic Evaluation of the SCOOP Study.
    Turner DA; Khioe RFS; Shepstone L; Lenaghan E; Cooper C; Gittoes N; Harvey NC; Holland R; Howe A; McCloskey E; O'Neill TW; Torgerson D; Fordham R;
    J Bone Miner Res; 2018 May; 33(5):845-851. PubMed ID: 29470854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term cost-effectiveness of screening for fracture risk in a UK primary care setting: the SCOOP study.
    Söreskog E; Borgström F; Shepstone L; Clarke S; Cooper C; Harvey I; Harvey NC; Howe A; Johansson H; Marshall T; O'Neill TW; Peters TJ; Redmond NM; Turner D; Holland R; McCloskey E; Kanis JA;
    Osteoporos Int; 2020 Aug; 31(8):1499-1506. PubMed ID: 32239237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A model-based cost-effectiveness analysis of osteoporosis screening and treatment strategy for postmenopausal Japanese women.
    Yoshimura M; Moriwaki K; Noto S; Takiguchi T
    Osteoporos Int; 2017 Feb; 28(2):643-652. PubMed ID: 27743068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening in the community to reduce fractures in older women (SCOOP): a randomised controlled trial.
    Shepstone L; Lenaghan E; Cooper C; Clarke S; Fong-Soe-Khioe R; Fordham R; Gittoes N; Harvey I; Harvey N; Heawood A; Holland R; Howe A; Kanis J; Marshall T; O'Neill T; Peters T; Redmond N; Torgerson D; Turner D; McCloskey E;
    Lancet; 2018 Feb; 391(10122):741-747. PubMed ID: 29254858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of a two-step population-based osteoporosis screening program using FRAX: the randomized Risk-stratified Osteoporosis Strategy Evaluation (ROSE) study.
    Rubin KH; Rothmann MJ; Holmberg T; Høiberg M; Möller S; Barkmann R; Glüer CC; Hermann AP; Bech M; Gram J; Brixen K
    Osteoporos Int; 2018 Mar; 29(3):567-578. PubMed ID: 29218381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic screening using FRAX
    Parsons CM; Harvey N; Shepstone L; Kanis JA; Lenaghan E; Clarke S; Fordham R; Gittoes N; Harvey I; Holland R; Redmond NM; Howe A; Marshall T; Peters TJ; Torgerson D; O'Neill TW; McCloskey E; Cooper C;
    Osteoporos Int; 2020 Jan; 31(1):67-75. PubMed ID: 31606826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. US Preventative Services Task Force FRAX threshold has a low sensitivity to detect osteoporosis in women ages 50-64 years.
    Bansal S; Pecina JL; Merry SP; Kennel KA; Maxson J; Quigg S; Thacher TD
    Osteoporos Int; 2015 Apr; 26(4):1429-33. PubMed ID: 25614141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-Effectiveness of the Screening for the Primary Prevention of Fragility Hip Fracture in Spain Using FRAX
    Martin-Sanchez M; Comas M; Posso M; Louro J; Domingo L; Tebé C; Castells X; Espallargues M
    Calcif Tissue Int; 2019 Sep; 105(3):263-270. PubMed ID: 31172231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of different screening strategies for osteoporosis in postmenopausal women.
    Nayak S; Roberts MS; Greenspan SL
    Ann Intern Med; 2011 Dec; 155(11):751-61. PubMed ID: 22147714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of Virtual Bone Strength Testing in Osteoporosis Screening Programs for Postmenopausal Women in the United States.
    Agten CA; Ramme AJ; Kang S; Honig S; Chang G
    Radiology; 2017 Nov; 285(2):506-517. PubMed ID: 28613988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for high hip fracture risk does not impact on falls risk: a post hoc analysis from the SCOOP study.
    Condurache CI; Chiu S; Chotiyarnwong P; Johansson H; Shepstone L; Lenaghan E; Cooper C; Clarke S; Khioe RFS; Fordham R; Gittoes N; Harvey I; Harvey NC; Heawood A; Holland R; Howe A; Kanis JA; Marshall T; O'Neill TW; Peters TJ; Redmond NM; Torgerson D; Turner D; McCloskey E;
    Osteoporos Int; 2020 Mar; 31(3):457-464. PubMed ID: 31960099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of fracture prevention in rural women with limited access to dual-energy X-ray absorptiometry.
    Ito K; Leslie WD
    Osteoporos Int; 2015 Aug; 26(8):2111-9. PubMed ID: 25807913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fall prevention interventions in primary care to reduce fractures and falls in people aged 70 years and over: the PreFIT three-arm cluster RCT.
    Bruce J; Hossain A; Lall R; Withers EJ; Finnegan S; Underwood M; Ji C; Bojke C; Longo R; Hulme C; Hennings S; Sheridan R; Westacott K; Ralhan S; Martin F; Davison J; Shaw F; Skelton DA; Treml J; Willett K; Lamb SE
    Health Technol Assess; 2021 May; 25(34):1-114. PubMed ID: 34075875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of the SALT Osteoporosis Study: a randomised pragmatic trial, to study a primary care screening and treatment program for the prevention of fractures in women aged 65 years or older.
    Elders PJM; Merlijn T; Swart KMA; van Hout W; van der Zwaard BC; Niemeijer C; Heymans MW; van der Heijden AA; Rutters F; van der Horst HE; Lips P; Netelenbos JC; van Schoor NM
    BMC Musculoskelet Disord; 2017 Oct; 18(1):424. PubMed ID: 29078762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of a fracture liaison service--a real-world evaluation after 6 years of service provision.
    Yong JH; Masucci L; Hoch JS; Sujic R; Beaton D
    Osteoporos Int; 2016 Jan; 27(1):231-40. PubMed ID: 26275439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fracture risk assessment tool (FRAX) and for the diagnosis of osteoporosis in Japanese middle-aged and elderly women: Chiba bone survey.
    Oka R; Ohira M; Suzuki S; Yoshida T; Koide H; Tanaka T; Tatsuno I
    Endocr J; 2018 Feb; 65(2):193-202. PubMed ID: 29151451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of Patients With High Baseline Hip Fracture Risk by FRAX Reduces Hip Fractures-A Post Hoc Analysis of the SCOOP Study.
    McCloskey E; Johansson H; Harvey NC; Shepstone L; Lenaghan E; Fordham R; Harvey I; Howe A; Cooper C; Clarke S; Gittoes N; Heawood A; Holland R; Marshall T; O'Neill TW; Peters TJ; Redmond N; Torgerson D; Kanis JA;
    J Bone Miner Res; 2018 Jun; 33(6):1020-1026. PubMed ID: 29480960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted assessment of fracture risk in women at midlife.
    Davis SR; Tan A; Bell RJ
    Osteoporos Int; 2015 Jun; 26(6):1705-12. PubMed ID: 25630574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vertebral fracture assessment (VFA) by lateral DXA scanning may be cost-effective when used as part of fracture liaison services or primary care screening.
    Clark EM; Carter L; Gould VC; Morrison L; Tobias JH
    Osteoporos Int; 2014 Mar; 25(3):953-64. PubMed ID: 24292107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.